686 effects on pruritus and sleep disturbance in patients with primary biliary cholangitis (pbc) after 1 year of treatment with seladelpar, a peroxisome proliferator-activated receptor delta agonist: results of an open-label phase 2 studyAndreas E. Kremer,Marlyn J. Mayo,Christopher L. Bowlus,Guy Neff,Mark G. Swain,Michael Galambos,Aparna Goel,Palak Trivedi,Gideon Hirschfield,Richard Aspinall,Stuart C. Gordon,Brian B. Borg,Stephen Harrison,Paul Thuluvath,David E. Jones,Yvonne Doerffel,Cynthia Levy,Carmen Stanca,David Sheridan,John M. Vierling,Mitchell L. Shiffman,Joseph Odin,Bruce Bacon,Tarek Hassanein,Douglas Thorburn,Christoph Berg,David Bernstein,Aliya Gulamhusein,Charles Landis,Adam Peyton,Lynsey Corless,Peter Buggisch,Marcus-Alexander Wörns, Sandrin Bergheanu,Monika Varga,Yu Li,Ke Yang,Klara Dickinson,Pol Boudes,Charles A. McWherter,Alexandra Steinberg,Yun-Jung ChoiGastroenterology(2020)引用 0|浏览59暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要